0 0 M o n t h 2 0 1 7 | V o L 0 0 0 | n A t U R E | 1 LEttER BRCA1-associated protein 1 (BAP1) is a potent tumour suppressor gene that modulates environmental carcinogenesis 1-3 . All carriers of inherited heterozygous germline BAP1-inactivating mutations (BAP1 +/− ) developed one and often several BAP1 −/− malignancies in their lifetime 4 , mostly malignant mesothelioma, uveal melanoma 2,5 , and so on 6-10 . Moreover, BAP1-acquired biallelic mutations are frequent in human cancers 8,11-14 . BAP1 tumour suppressor activity has been attributed to its nuclear localization, where it helps to maintain genome integrity 15-17 . The possible activity of BAP1 in the cytoplasm is unknown. Cells with reduced levels of BAP1 exhibit chromosomal abnormalities and decreased DNA repair by homologous recombination 18 , indicating that BAP1 dosage is critical. Cells with extensive DNA damage should die and not grow into malignancies. Here we discover that BAP1 localizes at the endoplasmic reticulum. Here, it binds, deubiquitylates, and stabilizes type 3 inositol-1,4,5-trisphosphate receptor (IP3R3), modulating calcium (Ca 2+ ) release from the endoplasmic reticulum into the cytosol and mitochondria, promoting apoptosis. Reduced levels of BAP1 in BAP1 +/− carriers cause reduction both of IP3R3 levels and of Ca 2+ flux, preventing BAP1 +/− cells that accumulate DNA damage from executing apoptosis. A higher fraction of cells exposed to either ionizing or ultraviolet radiation, or to asbestos, survive genotoxic stress, resulting in a higher rate of cellular transformation. We propose that the high incidence of cancers in BAP1 +/− carriers results from the combined reduced nuclear and cytoplasmic activities of BAP1. Our data provide a mechanistic rationale for the powerful ability of BAP1 to regulate geneenvironment interaction in human carcinogenesis.
than the reduced levels of BAP1, such as, for example, the many genetic mutations that are found in all tumour-derived cell lines. Cells from BAP1 +/− carriers contained approximately 50% of BAP1 protein compared with controls (Extended Data Fig. 1a-d ) and did not show any differences in growth or cell cycle progression (Extended Data Fig. 1e, f) .
Annexin V and propidium iodide staining, and western blot measuring cleaved caspase-3 levels, revealed that seven out of seven BAP1 +/− fibroblast cell cultures were more resistant to various apoptotic drugs than seven matched BAP1 WT fibroblast cell cultures (Fig. 1a, b and Extended Data Fig. 1g -l). We obtained similar results by downregulating BAP1 in BAP1 WT primary human mesothelial cells (Extended Data Fig. 1m ).
Although all known activities of BAP1 have been ascribed to its nuclear localization 2 , apoptosis is a process largely regulated in the cytoplasm. Subcellular fractionation of primary BAP1 WT fibroblasts, human mesothelial cells, cells of the malignant mesothelioma cell lines PPM-Mill, and HEK293 (Extended Data Fig. 2a ) revealed that extra-nuclear BAP1 was specifically present in the endoplasmic reticulum (ER) fraction, findings confirmed by electron microscopy (Fig. 1c ) and immunofluorescence (Extended Data Fig. 2b-e ). BAP1 ER levels were reduced more than nuclear levels in BAP1 +/− fibroblasts ( Fig. 1d and Extended Data Fig. 2f-h) .
The ER is the major store of intracellular Ca 2+ (refs 20, 21) . IP3Rs are ER channels that control Ca 2+ release from the ER to the cytoplasm and the mitochondria 22, 23 . Transient Ca 2+ release promotes mitochondrial ATP production; excessive or prolonged Ca 2+ release triggers apoptosis via mitochondrial Ca 2+ overload and opening of the mitochondrial permeability transition pore 24 . The drugs shown in Fig. 1a, b and Extended Data Fig. 1g -m induce apoptosis via ER Ca 2+ release 25 . We hypothesized that BAP1 was involved in the regulation of intracellular Ca 2+ homeostasis. We transfected BAP1 +/− and BAP1 WT fibroblasts with ER-targeted cameleon (D1ER), a fluorescent probe to measure Ca 2+ concentrations 23 . Cells were stimulated with bradykinin, an agonist that causes ER Ca 2+ release through the IP3Rs, or with H 2 O 2 . Compared with BAP1 WT , BAP1 +/− fibroblasts released lower amounts of Ca 2+ from the ER (Fig. 1e, Extended Data Fig. 3a-c and Supplementary Table 1 ), findings suggestive of reduced flow of Ca 2+ through the IP3Rs. Accordingly, we detected lower Ca 2+ concentrations in the cytosol and the mitochondrial matrix of BAP1 +/− compared with BAP1 WT fibroblasts stimulated with bradykinin ( Fig. 1f , Extended Data Fig. 3n and Supplementary Table 1 ). The results were reproducible in all seven BAP1 +/− and seven matching BAP1 WT fibroblasts studied, as well as in three cell cultures of primary human mesothelial cells in which BAP1 Letter reSeArCH was silenced (Extended Data Fig. 3o , p and Supplementary Table 2 ). We obtained similar results in mice adult fibroblasts (MAFs) we derived from Bap1 +/− mice 3 compared with Bap1 WT mice (Extended Data Fig. 3q , r and Supplementary Table 2 ).
To test whether cytoplasmic BAP1 modulates Ca 2+ fluxes independently from nuclear BAP1, we built three adenoviral chimaeras that specifically localized BAP1 to the nucleus (BAP1-Nu), the cytoplasm (BAP1-Cyt), and the outer surface of the ER (BAP1-ER) (Extended Data Fig. 4a ): only the cytoplasmic and ER chimaeras regulated Ca 2+ changes ( Fig. 1g , Extended Data Fig. 4b and Supplementary  Tables 1 and 2 ).
IP3Rs can be rapidly ubiquitylated and degraded by the proteasome 26 . Fibroblasts from BAP1 +/− donors contained reduced IP3R3 protein levels (the isoform that controls apoptosis 27 ) compared with BAP1 WT (Fig. 2A, B and Extended Data Fig. 5a-c) . Similarly, human malignant mesothelioma cells with mutated BAP1 (>60% of sporadic malignant mesotheliomas carry somatic BAP1 mutations 11, 14 ) contained reduced levels of IP3R3 (Extended Data Fig. 5d ). IP3R3 messenger RNA (mRNA) (ITPR3) levels measured by quantitative PCR with reverse transcription (qRT-PCR) were similar in BAP1 WT and BAP1 +/− fibroblasts (Extended Data Fig. 5e ), suggesting that the differences observed were not transcriptionally regulated. We hypothesized that BAP1 might deubiquitylate and stabilize IP3R3. We found that IP3R3 co-immunoprecipitated BAP1 (Fig. 2C) , findings supported by proximity ligation assay ( Fig. 2D ) and immunofluorescence (Extended Data Fig. 6a ). BAP1-IP3R3 co-immunoprecipitate was barely detectable in BAP1 +/− fibroblasts; BAP1 rescue significantly increased the amount of BAP1 that co-immunoprecipitated with IP3R3 ( Fig. 2E) . We confirmed the specificity of the BAP1 interaction with IP3R3 in HEK293 cells expressing Flag-BAP1 (Extended Data Fig. 6b ). Instead, overexpression of the Myc-tagged truncated BAP1 L-mutant (Myc-BAP1(L)) (the L family mutant BAP1, which lacks the amino (N) terminus domain 5 ) showed an almost complete loss of interaction with IP3R3 compared with Myc-tagged wild-type BAP1 (Myc-BAP1) (Fig. 2F ), while catalytically inactive BAP1(C91S) 2,19 did bind IP3R3 (Extended Data Fig. 6c ). We found that BAP1 binds the N terminus domain of IP3R3 (IP3R3(NT)) ( Fig. 2G ). Deletion fragments of BAP1 revealed that its catalytic domain (UCH) did not bind IP3R3(NT), while its middle portion (NORS) and, to a minor extent, the C-terminal portion (CTD, NLS) did (Extended Data Fig. 6e , f). Overexpression of the N terminus of the IP3R3 bound and sequestered BAP1, leading to decreased IP3R3 levels, an effect counterbalanced by BAP1 co-overexpression (Extended Data Fig. 6d ).
Silencing of BAP1 in BAP1 WT fibroblasts consistently caused a reduction of IP3R3 protein levels (Extended Data Fig. 7a) , with a concomitant reduction in mitochondrial Ca 2+ responses (Extended Data Fig. 7b , c and Supplementary Tables 1 and 2), and protection from apoptosis (Extended Data Fig. 7d ). Likewise, silencing of IP3R3 (Extended Data Fig. 7e ) in BAP1 WT fibroblasts reduced mitochondrial Ca 2+ concentration (Extended Data Fig. 7f , g and Supplementary Tables 1 and 2) and apoptosis (Extended Data Fig. 7h ). Similar results were obtained in human mesothelial cells (Extended Data Fig. 7i , j and Supplementary Table 2 ). Transduction of BAP1 +/− fibroblasts with adenoviruses encoding BAP1, but not the catalytically inactive mutant BAP1(C91S) 2, 19 , rescued IP3R3 protein levels ( Fig. 3a ) and mitochondrial Ca 2+ uptake (Fig. 3b , Extended Data Fig. 8j and Supplementary Tables 1 and 2) , and resulted in enhanced apoptosis ( Fig. 3c ). Similar results were obtained in Phi and HMESO cells (derived from two human malignant mesotheliomas with biallelic BAP1 mutations) in which we reintroduced BAP1 or BAP1(C91S), and in human mesothelial cells in which we silenced BAP1 and then reintroduced BAP1 or BAP1(C91S). BAP1 stabilized IP3R3 and increased mitochondrial Ca 2+ concentrations and apoptosis; BAP1(C91S) did not (Extended Data Fig. 8a-h and Supplementary  Table 2 ). Moreover, in contrast to BAP1, mutated BAP1(W) and BAP1(L) did not influence mitochondrial calcium concentration ([Ca 2+ ] m ) after 1 μM bradykinin stimulation (Extended Data Fig. 8i and Supplementary Table 2 ).
In vitro ubiquitylation assays using purified recombinant proteins revealed that BAP1 counteracted the ubiquitylation of IP3R3(NT) 
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] m (μM) Letter reSeArCH ( Fig. 3d ). The in vitro deubiquitylating activity of BAP1 on IP3R3(NT) became detectable 30 min after adding BAP1 to the reaction, and was stronger at 60 min ( Fig. 3e ). BAP1(C91S), despite being able to bind IP3R3 (Extended Data Fig. 6c ), failed to deubiquitylate IP3R3(NT) ( Fig. 3d , e and Extended Data Fig. 8k , l), emphasizing the requirement of BAP1 catalytic activity. Comet assays showed that BAP1 +/− fibroblasts had a reduced ability to repair DNA damage after exposure to ionizing radiation ( Fig. 4a and Extended Data Fig. 9a ), findings supported by kinetics analyses showing a prolonged phosphorylation of γ-H2A.X indicating that DNA repair was delayed ( Fig. 4b ). Despite the reduced ability of BAP1 +/− cells to repair ionizing radiation-induced DNA damage, clonogenic assays revealed increased survival of BAP1 +/− cells compared with BAP1 WT after ionizing radiation ( Fig. 4c and Extended Data Fig. 9b ). Moreover, ultraviolet radiation with UVA (340 nm) or UVB (312 nm) (UVB is a more potent carcinogen than UVA) induced ER Ca 2+ release, which was significantly impaired in BAP1 +/− fibroblasts (Extended Data Fig. 9c -e), and UVB induced prolonged phosphorylation of γ-H2A.X (Extended Data Fig. 9f ). Clonogenic assays in fibroblasts from BAP1 +/− individuals and matched controls, exposed to UVA or was incubated in vitro with ubiquitylated Flag-IP3R3(NT), followed by western blot. The ladder corresponds to ubiquitylated IP3R3(NT). Decimals: ubiquitylated IP3R3(NT) normalized to total immunoprecipitated IP3R3(NT) at 90 kDa (short exposure). For western blot source images, see Supplementary Fig. 2 . b, For source data, see Supplementary Table 2 .
Letter reSeArCH UVB, revealed a reproducible significant increase in colony formation in BAP1 +/− fibroblasts (24% increase with UVA, 132% with UVB) (Fig. 4d , e and Extended Data Fig. 9g ).
Moreover, we discovered that crocidolite asbestos increased intracellular Ca 2+ concentrations ( Fig. 4f , Extended Data Fig. 10a and Supplementary Table 1 ) and apoptosis ( Fig. 4g and Extended Data Fig. 10b ). Human mesothelial cells silenced for either BAP1 or IP3R3 and exposed to crocidolite displayed reduced intracellular Ca 2+ concentrations ( Fig. 4f , Extended Data Fig. 10a and Supplementary Table 1 ) and were resistant to apoptosis ( Fig. 4g and Extended Data Fig. 10b ). Similar results were obtained in THP-1, a human monocytic cell line in which we downregulated BAP1 with short interfering RNA (siRNA), emphasizing the general relevance of this mechanism (Extended Data Fig. 10c -e and Supplementary Table 2 ). We used an established protocol in which primary human mesothelial cells exposed to crocidolite in the presence of tumour necrosis factoralpha (TNFα) underwent in vitro transformation, measured as formation of three-dimensional foci 28 . Human mesothelial cells treated with siBAP1 and exposed to crocidolite showed a significant increase in foci formation ( Fig. 4h ). Silencing of IP3R3 was less effective in increasing foci formation than BAP1 silencing, indicating that both nuclear and cytoplasmic BAP1 act in concert to prevent malignant transformation ( Fig. 4h ). Moreover, transduction of either BAP1 or IP3R3 in human mesothelial cells silenced for BAP1 significantly reduced foci formation ( Fig. 4i ). To test the independent contribution of cytoplasmic and nuclear BAP1 to cellular transformation, we silenced BAP1 and then infected human mesothelial cells with the BAP1 chimaeras (Extended Data Fig. 4a ). Transduction with BAP1-Cyt that specifically localized to the cytoplasm, where it modulated intracellular Ca 2+ fluxes ( Fig. 1g ), significantly reduced foci formation to levels similar to those obtained using BAP1 ( Fig. 4j ). Cells infected with BAP1-Nu, which localized only to the nucleus, showed reduced foci formation although the reduction was significantly less than cells infected with BAP1 ( Fig. 4j ).
It is unlikely that mutated cytoplasmic BAP1 contributed to some of the biological effects observed. With one single exception in one case of uveal melanoma 12 , all BAP1 mutations described impair the ability of BAP1 to translocate into the nucleus, either because the NLS is deleted, as in the L and W BAP1 +/− fibroblasts studied here, or because the catalytic domain is inactive 8, [11] [12] [13] [14] 19 . Mutated cytoplasmic BAP1 forms amyloid-like aggregates and is biologically inactive 29 , although it may be detectable by immunostaining 2, 5, 11 . In the W and L cells, truncation removed a critical domain for the interaction with IP3R3 ( Fig. 2F ). Accordingly, mutated W and L BAP1 did not influence Ca 2+ signalling (Extended Data Fig. 8i and Supplementary Table 2 ). . f, ER Ca 2+ release in primary human mesothelial cells (HM) exposed to asbestos and transfected with siBAP1 or siIP3R3, or scrambled (see Extended Data Fig. 10a ); for source data, see Supplementary Table 1 . g, Reduced apoptosis in human mesothelial cells silenced for either BAP1 or IP3R3 exposed to asbestos. Western blot comparing cleaved caspase-3 levels (see Extended Data Fig. 10b ). Decimals: cleaved caspase-3/α-tubulin. h-j, Cytoplasmic BAP1 and IP3R3 levels influence foci formation in human mesothelial cells exposed to asbestos. Foci formation in human mesothelial cells silenced with scrambled siRNA, siBAP1, and siIP3R3 (h); human mesothelial cells silenced for BAP1 and transduced with Ad-GFP (control), Ad-BAP1, and Ad-IP3R3 (i); and human mesothelial cells silenced for BAP1 and transduced with Ad-BAP1, Ad-BAP1-Nu, and Ad-BAP1-Cyt (j). c-e, h-j, N = 3 culture replicates, representative of three (c, e, h, i) or two (d, j) independent experiments in biological replicates. Data shown as mean ± s.d. P value calculated using two-tailed unpaired Student's t-tests. *P < 0.05; **P < 0.01; ***P < 0.001.
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In summary, we have discovered that in the cytoplasm BAP1 localizes at the ER, where it binds, deubiquitylates, and stabilizes IP3R3, thus regulating ER Ca 2+ release and promoting apoptosis. Decreased levels of BAP1 lead to enhanced DNA damage (because of decreased nuclear BAP1 activity), reduced apoptosis (because of decreased cytoplasmic BAP1 activity), and increased cellular transformation (because of both decreased nuclear and cytoplasmic activities). The separate activities of BAP1 in the nucleus and cytoplasm provide a mechanistic rationale for the strong tumour suppressor activity of this deubiquitylase. Our data suggest that the reduced levels of BAP1 result in a tumour phenotype prevalently under genotoxic/stress conditions (gene-environment interaction). Accordingly, 70% of BAP1 +/− heterozygous mice developed malignant mesotheliomas within a year when exposed to asbestos, and none of the non-exposed BAP1 +/− mice developed malignant meso theliomas during the same period 3 . Although almost any tumour type has been reported in carriers of germline BAP1 mutations 1,2,4-10 , there is a prevalence of malignant mesothelioma, often caused by asbestos, and of melanomas and skin cancers, often caused by ultraviolet radiation 4 . These two environmental carcinogens induce DNA damage and cell death. The balance between DNA damage and cell death determines the outcome: the more DNA-damaged cells survive exposure, the higher the risk that one of them may grow into a malignancy. It is possible that the malignancies more frequently associated with the BAP1 cancer syndrome arise from tissues in which Ca 2+ -induced apoptosis plays a critical role in cellular transformation.
Our findings reveal the relevance of post-translational modifications in modulating gene-environment interactions in human carcinogenesis, are relevant to understanding the high incidence of environmentally related cancers in carriers of germline BAP1 mutations, and provide novel targets for the numerous human malignancies that carry acquired and inherited BAP1 mutations 1,2,6-13,30 .
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 

MethOdS
Subjects. BAP1 +/− mutant carriers and unaffected controls were recruited from the L and W families; they donated the skin biopsies from which we derived the fibroblast cell cultures studied here. In previous studies, we demonstrated that around 50% of L and W family members inherited heterozygous BAP1 mutations 5 . Except for being adult members of these two families, no other predefined inclusion/exclusion criteria were applied. Written informed consent was received from all participants (BAP1 +/− mutant carriers, and gender-and age-matched unaffected family members). Collection and use of patient information and samples were approved by the Institutional Review Board of the University of Hawaii (protocol number 14406). Germline BAP1 sequencing was conducted on genomic DNA extracted from peripheral blood using standard methods and analysed by bidirectional sequencing of the BAP1 gene in the Hawaii Cancer Consortium Queen Medical Center CLIA/CAP certified laboratory, as described 5 . Fourteen family members (seven BAP1 WT and seven BAP1 +/− ) volunteered their skin biopsies for these studies and they were matched by gender and age. Assuming a two-tailed type I error rate (alpha) equal to 0.05 and seven observations per group (14 total), we had 80% power to detect a standardized difference equal to 1.8. Since we found a statistical difference, we had sufficient power to detect a pre-specified effect size.
Primary cultures of human dermal fibroblasts were established in tissue culture from biopsies of sun-protected forearm skin from donors of different gender and age. Biopsies were taken using a 5 mm punch (Schuco) on skin site previously disinfected and anaesthetized 31 . Cell cultures. We derived human dermal skin fibroblasts from explants of skin biopsies from four BAP1 WT and four BAP1 +/− Wisconsin (W) family members, and three BAP1 WT and three BAP1 +/− Louisiana (L) family members. Fibroblasts were grown from these skin explants and cultured in Dulbecco modified Eagle's medium (DMEM) with glucose (4.5 g l −1 ), 2 mM l-glutamine, without sodium pyruvate (Corning Cellgro), supplemented with 10% (v/v) fetal bovine serum (FBS) (Gibco) and 1% penicillin-streptomycin 31 . All the experiments were performed on fibroblasts between tissue culture passages 7 and 15.
Primary human mesothelial cells. We routinely established human mesothelial cells in tissue culture from pleural fluids that accumulated in individuals with congestive heart failure or other non-malignant conditions, who provided written informed consent. Human mesothelial cells were characterized by immunohistochemistry and cultured in DMEM with 20% FBS, as previously described 32 . Independent human mesothelial cells cultures from three different donors between tissue culture passages 4 and 5 were used in the experiments described here; each experiment for each of these human mesothelial cell cultures was conducted in triplicate.
Malignant mesothelioma cell lines. PPM-Mill, Phi, HMESO, Rob 33 (established and provided by H.I.P.), and human embryonic kidney cells (HEK293, provided by P.P.) were grown in DMEM supplemented with 10% FBS and 1% penicillinstreptomycin. HMESO stable clones were generated as described below (see 'Gene silencing with siRNA, adenovirus-mediated gene transfer, and transfection'), and grown in DMEM with glucose (4.5 g l −1 ), 2 mM l-glutamine, without sodium pyruvate (Corning Cellgro), supplemented with 10% (v/v) FBS (Gibco), 1% penicillin-streptomycin, and 0.5 mg ml −1 G418 (Geneticin). THP-1 cells (human monocytic cell line from acute monocytic leukaemia,) were obtained from the American Type Culture Collection (ATCC) and cultured in RPMI-1640 Medium (Corning Cellgro) supplemented with 10% (v/v) FBS (Gibco) and 1% penicillinstreptomycin; treatment with 20 μM 12-O-tetradecanoylphorbol 13-acetate (TPA) for 24 h was performed to induce monocyte differentiation into macrophages 34 . MAF cell cultures were derived from 3-month-old Bap1 WT and Bap1 +/− mice 35 genotyped as described 35 ; MAFs were grown in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin. Cells were cultured in a humidified atmosphere of 5% (v/v) carbon dioxide in air at 37 °C. All cells used in the experiments reported here were routinely tested for mycoplasma contamination (about once a month) using a LookOut Mycoplasma PCR Detection Kit (Sigma-Aldrich, catalogue number MP0035) and were confirmed to be mycoplasma-free.
All main experiments were conducted in primary cells from human volunteers (fibroblasts and human mesothelial cells). Therefore, the results are related to the reduced levels of BAP1 present in cells derived from carriers of heterozygous germline BAP1 mutations and to the reduced levels of BAP1 we induced in primary human mesothelial cells by siRNA. In other words, the results presented could not be influenced by the numerous genetic alterations that are found in tumour-derived cell lines. Some confirmatory experiments were conducted in cell lines. None of the cell lines used in this paper were found in the International Cell Line Authentication Committee or National Center for Biotechnology Information Biosample databases of misidentified cell lines. Short-tandem repeat analyses were performed upon arrival of these cell lines in our laboratory for authentication.
Re-authentication of the cell lines confirming their identity was performed by 'Genetica DNA Laboratories, LabCorp' in July 2015. Growth curves. Fibroblast cell culture proliferation was measured using an AlamarBlue assay (AbD Serotec, catalogue number BUF012B). After incubation of the cells in 96-well plates, 10% v/v AlamarBlue was added and fluorescence was measured (excitation 560 nm, emission 590 nm) at the indicated time points. Gene silencing with siRNA, adenovirus-mediated gene transfer, and transfection. siRNA oligonucleotides were obtained from Qiagen. GeneSoluton siRNAs targeting four different BAP1 mRNAs were as follows: Hs_BAP1_1, catalogue number SI00066696; Hs_BAP1_2, catalogue number SI00066703; Hs_BAP1_3, catalogue number SI00066710; Hs_BAP1_5, catalogue number SI03036390. GeneSoluton siRNAs targeting four different IP3R3 mRNAs (ITPR3) were as follows: Hs_ITPR3_1, catalogue number SI00034580; Hs_ ITPR3_2, catalogue number SI00034587; Hs_ ITPR3_3, catalogue number SI00034594; Hs_ ITPR3_4, catalogue number SI00034601. Negative control siRNA was catalogue number 1027280. Transfection was performed with HiPerfect (Qiagen), using siRNAs at 10 nM final concentrations in 0.1% FBS medium for 24 h. Unless otherwise specified in the figures, a pool of the four different siRNAs, listed above, was used to silence BAP1 or IP3R3.
Adenoviruses expressing BAP1 and GFP were purchased from SignaGen Laboratories (Ad-BAP1, catalogue number SL175127; Ad-GFP, catalogue number SL100708). Customized adenoviruses expressing Ad-Myc-BAP1, Ad-Myc-BAP1(C91S), Ad-Myc-BAP1(W), and Ad-Myc-BAP1(L) were produced by SignaGen Laboratories using their Ad.MAX System. Expression plasmids for Flag-HA-BAP1, Myc-BAP1, Myc-BAP1(W), Myc-BAP1(L), and Myc-BAP1(C91S) were produced by Blue Heron Biotech. For BAP1(W), BAP1(L), and BAP1(C91S), the following nucleotide sequences were used.
BAP1 (L): ATGAATAAGGGCTGGCTGGAGCTGGAGAGCGACCCAG  GCCTCTTCACCCTGCTCGTGGAAGATTTCGGTGTCAAGGGGGTGCAA  GTGGAGGAGATCTACGACCTTCAGAGCAAATGTCAGGGCCCTGTATAT  GGATTTATCTTCCTGTTCAAATGGATCGAAGAGCGCCGGTCCCGGCGA  AAGGTCTCTACCTTGGTGGATGATACGTCCGTGATTGATGATGATATTG  TGAATAACATGTTCTTTGCCCACCAGCTGATACCCAACTCTTGTGCAAC  TCATGCCTTGCTGAGCGTGCTCCTGAACTGCAGCAGCGTGGACCTGGG  ACCCACCCTGAGTCGCATGAAGGACTTCACCAAGGGTTTCAGCCCTG  AGAGCAAAGGATATGCGATTGGCAATGCCCCGGAGTTGGCCAAGGCC  CATAATAGCCATGCCAGGCCCGAGCCACGCCACCTCCCTGAGAAGCA  GAATGGCCTTAGTGCAGTGCGGACCATGGAGGCGTTCCACTTTGTCAG  CTATGTGCCTATCACAGGCCGGCTCTTTGAGCTGGATGGGCTGAAGGT  CTACCCCATTGACCATGGGCCCTGGGGGGAGGACGAGGAGTGGACAG  ACAAGGCCCGGCGGGTCATCATGGAGCGTATCGGCCTCGCCACTGCA  GGGGAGCCCTACCACGACATCCGCTTCAACCTGATGGCAGTGGTGCC  CGACCGCAGGATCAAGTATGAGGCCAGGCTGCATGTGCTGAAGGTGA  ACCGTCAGACAGTACTAGAGGCTCTGCAGCAGCTGATAAGAGTAACAC  AGCCAGAGCTGATTCAGACCCACAAGTCTCAAGAGTCACAGCTGCCTG  AGGAGTCCAAGTCAGCCAGCAACAAGTCCCCGCTGGTGCTGGAAGCAA  ACAGGGCCCCTGCAGCCTCTGAGGGCAACCACACAGATGGTGCAGAGG  AGGCGGCTGGTTCATGCGCACAAGCCCCATCCCACAGCCCTCCCAACA  AACCCAAGCTAGTGGTGAAGCCTCCAGGCAGCAGCCTCAATGGGGTTC  ACCCCAACCCCACTCCCATTGTCCAGCGGCTGCCGGCCTTTCTAGACA  ATCACAATTATGCCAAGTCCCCCATGCAGGAGGAAGAAGACCTGGCGG  CAGGTGTGGGCCGCAGCCGAGTTCCAGTCCGCCCACCCCAGCAGTACT  CAGATGATGAGGATGACTATGAGGATGACGAGGAGGATGACGTGCAGA  ACACCAACTCTGCCCTTAGGTATAAGGGGAAGGGAACAGGGAAGCCAG  GGGCATTGAGCGGTTCTGCTGATGGGCAACTGTCAGTGCTGCAGCCCA  ACACCATCAACGTCTTGGCTGAGAAGCTCAAAGAGTCCCAGAAGGACC  TCTCAATTCCTCTGTCCATCAAGACTAGCAGCGGGGCTGGGAGTCCGG  CTGTGGCAGTGCCCACACACTCGCAGCCCTCACCCACCCCCAGCAATG  AGAGTACAGACACGGCCTCTGAGATCGGCAGTGCTTTCAACTCGCCAC  Letter reSeArCH   TGCGCTCGCCTATCCGCTCAGCCAACCCGACGCGGCCCTCCAGCCCTG  TCACCTCCCACATCTCCAAGGTGCTTTTTGGAGAGGATGACAGCCTGC  TGCGTGTTGACTGCATACGCTACAACCGTGCTGTCCGTGATCTGGGTC  CTGTCATCAGCACAGGCCTGCTGCACCTGGCTGAGGATGGGGTGCTGA  GTCCCCTGGCGCTGACAGAGGGTGGGAAGGGTTCCTCGCCCTCCATCA  GACCAATCCAAGGCAGCCAGGGGTCCAGCAGCCCAGTGGAGAAGGAG  GTCGTGGAAGCCACGGACAGCAGAGAGAAGACGGGGATGGTGAGGC  CTGGCGAGCCCTTGAGTGGGGAGAAATACTCACCCAAGGAGCTGCTGG  CACTGCTGAAGTGTGTGGAGGCTGAGATTGCAAACTATGAGGCGTGCCT  CAAGGAGGAGGTAGAGAAGAGGAAGAAGTTCAAGATTGATGACCAGAG  AAGGACCCACAACTACGATGAGTTCATCTGCACCTTTATCTCCATGCTG  GCTTAG.  BAP1(C91S): ATGAATAAGGGCTGGCTGGAGCTGGAGAGCGACC  CAGGCCTCTTCACCCTGCTCGTGGAAGATTTCGGTGTCAAGGGGGTGC  AAGTGGAGGAGATCTACGACCTTCAGAGCAAATGTCAGGGCCCTGTATA  TGGATTTATCTTCCTGTTCAAATGGATCGAAGAGCGCCGGTCCCGGCGA  AAGGTCTCTACCTTGGTGGATGATACGTCCGTGATTGATGATGATATTG  TGAATAACATGTTCTTTGCCCACCAGCTGATACCCAACTCTAGTGCAAC  TCATGCCTTGCTGAGCGTGCTCCTGAACTGCAGCAGCGTGGACCTGGG  ACCCACCCTGAGTCGCATGAAGGACTTCACCAAGGGTTTCAGCCCTGA  GAGCAAAGGATATGCGATTGGCAATGCCCCGGAGTTGGCCAAGGCCCA  TAATAGCCATGCCAGGCCCGAGCCACGCCACCTCCCTGAGAAGCAGAA  TGGCCTTAGTGCAGTGCGGACCATGGAGGCGTTCCACTTTGTCAGCTAT  GTGCCTATCACAGGCCGGCTCTTTGAGCTGGATGGGCTGAAGGTCTAC  CCCATTGACCATGGGCCCTGGGGGGAGGACGAGGAGTGGACAGACAA  GGCCCGGCGGGTCATCATGGAGCGTATCGGCCTCGCCACTGCAGGGGA  GCCCTACCACGACATCCGCTTCAACCTGATGGCAGTGGTGCCCGACCGC  AGGATCAAGTATGAGGCCAGGCTGCATGTGCTGAAGGTGAACCGTCAG  ACAGTACTAGAGGCTCTGCAGCAGCTGATAAGAGTAACACAGCCAGAG  CTGATTCAGACCCACAAGTCTCAAGAGTCACAGCTGCCTGAGGAGTCC  AAGTCAGCCAGCAACAAGTCCCCGCTGGTGCTGGAAGCAAACAGGGC  CCCTGCAGCCTCTGAGGGCAACCACACAGATGGTGCAGAGGAGGCGGC  TGGTTCATGCGCACAAGCCCCATCCCACAGCCCTCCCAACAAACCCAA  GCTAGTGGTGAAGCCTCCAGGCAGCAGCCTCAATGGGGTTCACCCCA  ACCCCACTCCCATTGTCCAGCGGCTGCCGGCCTTTCTAGACAATCACAA  TTATGCCAAGTCCCCCATGCAGGAGGAAGAAGACCTGGCGGCAGGTG  TGGGCCGCAGCCGAGTTCCAGTCCGCCCACCCCAGCAGTACTCAGATG  ATGAGGATGACTATGAG GATGACGAGGAGGATGACGTGCAGAACA  CCAACTCTGCCCTTAGGTATAAGGGGAAGGGAACAGGGAAGCCAGGG  GCATTGAGCGGTTCTGCTGATGGGCAACTGTCAGTGCTGCAGCCCAAC  ACCATCAACGTCTTGGCTGAGAAGCTCAAAGAGTCCCAGAAGGACCT  CTCAATTCCTCTGTCCATCAAGACTAGCAGCGGGGCTGGGAGTCCGGC  TGTGGCAGTGCCCACACACTCGCAGCCCTCACCCACCCCCAGCAATGAG  AGTACAGACACGGCCTCTGAGATCGGCAGTGCTTTCAACTCGCCACTGC  GCTCGCCTATCCGCTCAGCCAACCCGACGCGGCCCTCCAGCCCTGTCA  CCTCCCACATCTCCAAGGTGCTTTTTGGAGAGGATGACAGCCTGCTGC  GTGTTGACTGCATACGCTACAACCGTGCTGTCCGTGATCTGGGTCCTG  TCATCAGCACAGGCCTGCTGCACCTGGCTGAGGATGGGGTGCTGAGTC  CCCTGGCGCTGACAGAGGGTGGGAAGGGTTCCTCGCCCTCCATCAGAC  CAATCCAAGGCAGCCAGGGGTCCAGCAGCCCAGTGGAGAAGGAGGTC  GTGGAAGCCACGGACAGCAGAGAGAAGACGGGGATGGTGAGGCCTGG  CGAGCCCTTGAGTGGGGAGAAATACTCACCCAAGGAGCTGCTGGCACT  GCTGAAGTGTGTGGAGGCTGAGATTGCAAACTATGAGGCGTGCCTCAA  GGAGGAGGTAGAGAAGAGGAAGAAGTTCAAGATTGATGACCAGAGAAG  GACCCACAACTACGATGAGTTCATCTGCACCTTTATCTCCATGCTGGCT  CAGGAAGGCATGCTGGCCAACCTAGTGGAGCAGAACATCTCCGTGCGG  CGGCGCCAAGGGGTCAGCATCGGCCGGCTCCACAAGCAGCGGAAGCCT  GACCGGCGGAAACGCTCTCGCCCCTACAAGGCCAAGCGCCAGTGA. Customized adenoviruses expressing Ad-Myc-BAP1-ER, Ad-Myc-BAP1-Nu, and Ad-Myc-BAP1-Cyt were produced by SignaGen Laboratories. The respective expression plasmids were produced by Blue Heron Biotech. The following nucleotide sequences were used and cloned into the expression vector pCMV6-AN-My (catalogue number PS100012). CCTCTTCACCCTGCTCGTGGAAGATTTCGGTGTCAAGGGGGTGCAA GT  GGAGGAGATCTACGACCTTCAGAGCAAATGTCAGGGCCCTGTATATGGA  TTTATCTTCCTGTTCAAATGGATCGAAGAGCGCCGGTCCCGGCGAAAG  GTCTCTACCTTGGTGGATGATACGTCCGTGATTGATGATGATATTGTGAA  TAACATGTTCTTTGCCCACCAGCTGATACCCAACTCTTGTGCAACTCAT  GCCTTGCTGAGCGTGCTCCTGAACTGCAGCAGCGTGGACCTGGGACCC  ACCCTGAGTCGCATGAAGGACTTCACCAAGGGTTTCAGCCCTGAGAGC  AAAGGATATGCGATTGGCAATGCCCCGGAGTTGGCCAAGGCCCATAAT   AGCCATGCCAGGCCCGAGCCACGCCACCTCCCTGAGAAGCAGAATGG  CCTTAGTGCAGTGCGGACCATGGAGGCGTTCCACTTTGTCAGCTATGTG  CCTATCACAGGCCGGCTCTTTGAGCTGGATGGGCTGAAGGTCTACCCCA  TTGACCATGGGCCCTGGGGGGAGGACGAGGAGTGGACAGACAAGGCC  CGGCGGGTCATCATGGAGCGTATCGGCCTCGCCACTGCAGGGGAGCC  CTACCACGACATCCGCTTCAACCTGATGGCAGTGGTGCCCGACCGCAG  GATCAAGTATGAGGCCAGGCTGCATGTGCTGAAGGTGAACCGTCAGAC  AGTACTAGAGGCTCTGCAGCAGCTGATAAGAGTAACACAGCCAGAGCT  GATTCAGACCCACAAGTCTCAAGAGTCACAGCTGCCTGAGGAGTCCAA  GTCAGCCAGCAACAAGTCCCCGCTGGTGCTGGAAGCAAACAGGGCCCC  TGCAGCCTCTGAGGGCAACCACACAGATGGTGCAGAGGAGGCGGCTG  GTTCATGCGCACAAGCCCCATCCCACAGCCCTCCCAACAAACCCAAGC  TAGTGGTGAAGCCTCCAGGCAGCAGCCTCAATGGGGTTCACCCCAACC  CCACTCCCATTGTCCAGCGGCTGCCGGCCTTTCTAGACAATCACAATT  ATGCCAAGTCCCCCATGCAGGAGGAAGAAGACCTGGCGGCAGGTGTGG  GCCGCAGCCGAGTTCCAGTCCGCCCACCCCAGCAGTACTCAGATGATG  AGGATGACTATGAGGATGACGAGGAGGATGACGTGCAGAACACCAAC  TCTGCCCTTAGGTATAAGGGGAAGGGAACAGGGAAGCCAGGGGCATTG  AGCGGTTCTGCTGATGGGCAACTGTCAGTGCTGCAGCCCAACACCATC  AACGTCTTGGCTGAGAAGCTCAAAGAGTCCCAGAAGGACCTCTCAATT  CCTCTGTCCATCAAGACTAGCAGCGGGGCTGGGAGTCCGGCTGTGGCA  GTGCCCACACACTCGCAGCCCTCACCCACCCCCAGCAATGAGAGTACA  GACACGGCCTCTGAGATCGGCAGTGCTTTCAACTCGCCACTGCGCTCG  CCTATCCGCTCAGCCAACCCGACGCGGCCCTCCAGCCCTGTCACCTCC  CACATCTCCAAGGTGCTTTTTGGAGAGGATGACAGCCTGCTGCGTGTT  GACTGCATACGCTACAACCGTGCTGTCCGTGATCTGGGTCCTGTCATC  AGCACAGGCCTGCTGCACCTGGCTGAGGATGGGGTGCTGAGTCCCCT  GGCGCTGACAGAGGGTGGGAAGGGTTCCTCGCCCTCCATCAGACCAA  TCCAAGGCAGCCAGGGGTCCAGCAGCCCAGTGGAGAAGGAGGTCG TG  GAAGCCACGGACAGCAGAGAGAAGACGGGGATGGTGAGGCCTGGCGA  GCCCTTGAGTGGGGAGAAATACTCACCCAAGGAGCTGCTGGCACTGCT  GAAGTGTGTGGAGGCTGAGATTGCAAACTATGAGGCGTGCCTCAAGG  AGGAGGTAGAGAAGAGGAAGAAGTTCAAGATTGATGACCAGAGAAGG  ACCCACAACTACGATGAGTTCATCTGCACCTTTATCTCCATGCTGGCT  CAGGAAGGCATGCTGGCCAACCTAGTGGAGCAGAACATCTCCGTGCG  GCGGCGCCAAGGGGTCAGCATCGGCCGGCTCCACAAGCAGCGGAAGC  CTGACCGGCGGAAACGCTCTCGCCCCTACAAGGCCAAGCGCCAGATG  GTTTATATTGGTATCGCTATTTTTTTGTTTTTGGTTGGCCTTTTTATGA  AATGA. ER targeting sequence: ATGGTTTATATTGGTATCGCTATTTTTTTG TTTTTGGTTGGCCTTTTTATGAAA.
BAP1-ER: ATGAATAAGGGCTGGCTGGAGCTGGAGAGCGACCCAGG
BAP1 -Nu: ATGAATAAGGGCTGGCTGGAGCTGGAGAGCGACCCAG  GCCTCTTCACCCTGCTCGTGGAAGATTTCGGTGTCAAGGGGGTGCAAG  TGGAGGAGATCTACGACCTTCAGAGCAAATGTCAGGGCCCTGTATATG  GATTTATCTTCCTGTTCAAATGGATCGAAGAGCGCCGGTCCCGGCGAAA  GGTCTCTACCTTGGTGGATGATACGTCCGTGATTGATGATGATATTGTG  AATAACATGTTCTTTGCCCACCAGCTGATACCCAACTCTTGTGCAACTC  ATGCCTTGCTGAGCGTGCTCCTGAACTGCAGCAGCGTGGACCTGGGAC  CCACCCTGAGTCGCATGAAGGACTTCACCAAGGGTTTCAGCCCTGAGA  GCAAAGGATATGCGATTGGCAATGCCCCGGAGTTGGCCAAGGCCCATA  ATAGCCATGCCAGGCCCGAGCCACGCCACCTCCCTGAGAAGCAGAATG  GCCTTAGTGCAGTGCGGACCATGGAGGCGTTCCACTTTGTCAGCTATG  TGCCTATCACAGGCCGGCTCTTTGAGCTGGATGGGCTGAAGGTCTACC  CCATTGACCATGGGCCCTGGGGGGAGGACGAGGAGTGGACAGACAAG  GCCCGGCGGGTCATCATGGAGCGTATCGGCCTCGCCACTGCAGGGGAG  CCCTACCACGACATCCGCTTCAACCTGATGGCAGTGGTGCCCGACCGCA  GGATCAAGTATGAGGCCAGGCTGCATGTGCTGAAGGTGAACCGTCAGA  CAGTACTAGAGGCTCTGCAGCAGCTGATAAGAGTAACACAGCCAGAGC  TGATTCAGACCCACAAGTCTCAAGAGTCACAGCTGCCTGAGGAGTCCA  AGTCAGCCAGCAACAAGTCCCCGCTGGTGCTGGAAGCAAACAGGGCC  CCTGCAGCCTCTGAGGGCAACCACACAGATGGTGCAGAGGAGGCGGC  TGGTTCATGCGCACAAGCCCCATCCCACAGCCCTCCCAACAAACCCAA  GCTAGTGGTGAAGCCTCCAGGCAGCAGCCTCAATGGGGTTCACCCCAA  CCCCACTCCCATTGTCCAGCGGCTGCCGGCCTTTCTAGACAATCACAA  TTATGCCAAGTCCCCCATGCAGGAGGAAGAAGACCTGGCGGCAGGTGT  GGGCCGCAGCCGAGTTCCAGTCCGCCCACCCCAGCAGTACTCAGATGA  TGAGGATGACTATGAGGATGACGAGGAGGATGACGTGCAGAACACCAA  CTCTGCCCTTAGGTATAAGGGGAAGGGAACAGGGAAGCCAGGGGCAT  TGAGCGGTTCTGCTGATGGGCAACTGTCAGTGCTGCAGCCCAACACCA  TCAACGTCTTGGCTGAGAAGCTCAAAGAGTCCCAGAAGGACCTCTCAA  TTCCTCTGTCCATCAAGACTAGCAGCGGGGCTGGGAGTCCGGCTGTGG  CAGTGCCCACACACTCGCAGCCCTCACCCACCCCCAGCAATGAGAGTA  Letter  reSeArCH   CAGACACGGCCTCTGAGATCGGCAGTGCTTTCAACTCGCCACTGCGCT  CGCCTATCCGCTCAGCCAACCCGACGCGGCCCTCCAGCCCTGTCACCT  CCCACATCTCCAAGGTGCTTTTTGGAGAGGATGACAGCCTGCTGCGTG  TTGACTGCATACGCTACAACCGTGCTGTCCGTGATCTGGGTCCTGTCA  TCAGCACAGGCCTGCTGCACCTGGCTGAGGATGGGGTGCTGAGTCCC  CTGGCGCTGACAGAGGGTGGGAAGGGTTCCTCGCCCTCCATCAGACCA  ATCCAAGGCAGCCAGGGGTCCAGCAGCCCAGTGGAGAAGGAGGTCGTG  GAAGCCACGGACAGCAGAGAGAAGACGGGGATGGTGAGGCCTGGCG  AGCCCTTGAGTGGGGAGAAATACTCACCCAAGGAGCTGCTGGCACTG  CTGAAGTGTGTGGAGGCTGAGATTGCAAACTATGAGGCGTGCCTCAAG  GAGGAGGTAGAGAAGAGGAAGAAGTTCAAGATTGATGACCAGAGAAG  GACCCACAACTACGATGAGTTCATCTGCACCTTTATCTCCATGCTGGCT  CAGGAAGGCATGCTGGCCAACCTAGTGGAGCAGAACATCTCCGTGCG  GCGGCGCCAAGGGGTCAGCATCGGCCGGCTCCACAAGCAGCGGAAGC  CTGACCGGCGGAAACGCTCTCGCCCCTACAAGGCCAAGCGCCAGACA  GTTTTTTCTAATGGCTATTCAAGCCCCAGCATGAGACCAGATGTAAGCT  CTCCTCCATCCAGCTCCTCAACAGCAACAACAGGACCACCTCCCAAAC  TCTGCCTGGTGTGCTCTGATGAAGCTTCAGGATGTCATTATGGAGTCT  TAACTTGTGGAAGCTGTAAAGTTTTCTTCAAAAGAGCAGTGGAAGGACA  GCACAATTACCTATGTGCTGGAAGGAATGATTGCATCATCGATAAAATT  CGAAGAAAAAACTGCCCAGCATGCCGCTATCGAAAATGTCTTCAGGCT  GGAATGAACCTGGAAGCTCGAAAAACAAAGAAAAAAATAAAAGGAAT  TCAGCAGGCCACTTGA.  Nuclear targeting sequence: ACAGTTTTTTCTAATGGCTATTCAAG  CCCCAGCATGAGACCAGATGTAAGCTCTCCTCCATCCAGCTCCTCAAC  AGCAACAACAGGACCACCTCCCAAACTCTGCCTGGTGTGCTCTGATGA  AGCTTCAGGATGTCATTATGGAGTCTTAACTTGTGGAAGCTGTAAAGT  TTTCTTCAAAAGAGCAGTGGAAGGACAGCACAATTACCTATGTGCTGG  AAGGAATGATTGCATCATCGATAAAATTCGAAGAAAAAACTGCCCAGCA  TGCCGCTATCGAAAATGTCTTCAGGCTGGAATGAACCTGGAAGCTCGA  AAAACAAAGAAAAAAATAAAAGGAATTCAGCAGGCCACT.  BAP1-Cyt: ATGAATAAGGGCTGGCTGGAGCTGGAGAGCGACCCAG  GCCTCTTCACCCTGCTCGTGGAAGATTTCGGTGTCAAGGGGGTGCAA  GTGGAGGAGATCTACGACCTTCAGAGCAAATGTCAGGGCCCTGTATAT  GGATTTATCTTCCTGTTCAAATGGATCGAAGAGCGCCGGTCCCGGCGA  AAGGTCTCTACCTTGGTGGATGATACGTCCGTGATTGATGATGATATTG  TGAATAACATGTTCTTTGCCCACCAGCTGATACCCAACTCTTGTGCAAC  TCATGCCTTGCTGAGCGTGCTCCTGAACTGCAGCAGCGTGGACCTGG  GACCCACCCTGAGTCGCATGAAGGACTTCACCAAGGGTTTCAGCCCT  GAGAGCAAAGGATATGCGATTGGCAATGCCCCGGAGTTGGCCAAGGC  CCATAATAGCCATGCCAGGCCCGAGCCACGCCACCTCCCTGAGAAGCA  GAATGGCCTTAGTGCAGTGCGGACCATGGAGGCGTTCCACTTTGTCAG  CTATGTGCCTATCACAGGCCGGCTCTTTGAGCTGGATGGGCTGAAGGT  CTACCCCATTGACCATGGGCCCTGGGGGGAGGACGAGGAGTGGACAG  ACAAGGCCCGGCGGGTCATCA TGGAGCGTATCGGCCTCGCCACTGC  AGGGGAGCCCTACCACGACATCCGCTTCAACCTGATGGCAGTGGTGCC  CGACCGCAGGATCAAGTATGAGGCCAGGCTGCATGTGCTGAAGGTGAA  CCGTCAGACAGTACTAGAGGCTCTGCAGCAGCTGATAAGAGTAACACA  GCCAGAGCTGATTCAGACCCACAAGTCTCAAGAGTCACAGCTGCCTGA  GGAGTCCAAGTCAGCCAGCAACAAGTCCCCGCTGGTGCTGGAA GCAA  ACAGGGCCCCTGCAGCCTCTGAGGGCAACCACACAGATGGTGCAGAGG  AGGCGGCTGGTTCATGCGCACAAGCCCCATCCCACAGCCCTCCCAAC  AAACCCAAGCTAGTGGTGAAGCCTCCAGGCAGCAGCCTCAATGGGGT  TCACCCCAACCCCACTCCCATTGTCCAGCGGCTGCCGGCCTTTCTAGAC  AATCACAATTATGCCAAGTCCCCCATGCAGGAGGAAGAAGACCTGGCG  GCAGGTGTGGGCCGCAGCCGAGTTCCAGTCCGCCCACCCCAGCAGTA  CTCAGATGATGAGGATGACTATGAGGATGACGAGGAGGATGACGTGCA  GAACACCAACTCTGCCCTTAGGTATAAGGGGAAGGGAACAGGGAAGC  CAGGGGCATTGAGCGGTTCTGCTGATGGGCAACTGTCAGTGCTGCAG  CCCAACACCATCAACGTCTTGGCTGAGAAGCTCAAAGAGTCCCAGAAG  GACCTCTCAATTCCTC TGTCCATCAAGACTAGCAGCGGGGCTGG  GAGTCCGGCTGTGGCAGTGCCCACACACTCGCAGCCCTCACCCACCCC  CAGCAATGAGAGTACAGACACGGCCTCTGAGATCGGCAGTGCTTTCAA  CTCGCCACTGCGCTCGCCTATCCGCTCAGCCAACCCGACGCGGCCCTC  CAGCCCTGTCACCTCCCACATCTCCAAGGTGCTTTTTGGAGAGGATGA  CAGCCTGCTGCGTGTTGACTGCATACGCTACAACCGTGCTGTCCGTGA  TCTGGGTCCTGTCATCAGCACAGGCCTGCTGCACCTGGCTGAGGATGG  GGTGCTGAGTCCCCTGGCGCTGACAGAGGGTGGGAAGGGTTCCTCGCC  CTCCATCAGACCAATCCAAGGCAGCCAGGGGTCCAGCAGCCCAGTGGA  GAAGGAGGTCGTGGAAGCCACGGACAGCAGAGAGAAGACGGGGATGG  TGAGGCCTGGCGAGCCCTTGAGTGGGGAGAAATACTCACCCAAGGAGC  TGCTGGCACTGCTGAAGTGTGTGGAGGCTGAGATTGCAAACTATGAGG   CGTGCCTCAAGGAGGAGGTAGAGAAGAGGAAGAAGTTCAAGATTGATG  ACCAGAGAAGGACCCACAACTACGATGAGTTCATCTGCACCTTTATCT  CCATGCTGGCTCAGGAAGGCATGCTGGCCAACCTAGTGGAGCAGAACA  TCTCCGTGGCGGCGGCGCAAGGGGTCAGCATCGGCGCGCTCCACAAGC  AGCGGAAGCCTGACGCGGCGGCGGCGGCGGCGCCCTACAAGGCCAA  GCGCCAGTGA. Point mutations (in bold type) introduced in the BAP1 NLS region (according to ref. 19 
The customized adenovirus expressing Ad-IP3R3 was produced by Vector BioLabs, from the expression plasmid ITPR3 (Myc-DDK-tagged)-Human inositol 1,4,5-trisphosphate receptor, type 3, obtained from Blue Heron Biotech (catalogue number RC222737).
The adenoviruses expressing Ad-cytAEQ, Ad-mtAEQ, and Ad-mtAEQmut were obtained from the laboratory of P.P. 36 .
Plasmids expressing Flag-IP3R3(NT), HA-IP3R3(NT), HA-IP3R3(MID), and HA-IP3R3(CT) were generated by S.K.
Blue Heron Biotech produced the plasmid DNA vectors expressing the six Myctagged BAP1 fragments: Myc-BAP1(UCH), amino acids 1-240; Myc BAP1(NORS), amino acids 240-598, Myc-BAP1(CTD-NLS), amino acids 598-729; Myc-BAP1(UCH-NORS-CTD), amino acids 1-699; Myc-BAP1(UCH-NORS), amino acids 1-598; Myc-BAP1(NORS-CTD-NLS), amino acids 240-729.
Cells (fibroblast cell cultures, human mesothelial cells, MAFs, Phi, HMESO, macrophages, as indicated in the figures) were seeded and allowed to grow to 50% confluence for 24 h before transduction or transfection. Infection with the indicated adenoviruses was performed at a multiplicity of infection of 100 plaque-forming units per cell, in 10% FBS. For aequorin measurements, the cells were seeded onto 13 mm glass coverslips. Experiments were performed 36 h after transduction. When silencing and transduction occurred together in the same experiment, cells were first transduced for 12 h and then transfected with HiPerfect for the remaining 24 h. THP-1 cells were treated with 20 μM TPA for 24 h to induce monocyte differentiation into macrophages; subsequently cells were transduced with WT mitochondrial-targeted aequorin (Ad-mtAEQ) for 24 h in the presence of TPA, and then transfected with control scrambled siRNA or siRNA-BAP1 (siBAP1#1 and siBAP1#5), in 1% FBS media, for an additional 24 h before Ca 2+ measurements. For cell imaging experiments, cells were seeded onto 24 mm glass coverslips and allowed to grow to 50% confluence before transduction or transfection.
Transfection with the ER-targeted (D1ER) and the mitochondrial-targeted (4mtD3cpv) Ca 2+ biosensors 23, 37 was performed using Lipofectamine LTX&PLUS (Life Technologies, 15338-100). HEK293 cells were cultured for 24 h, transiently transfected using polyethylenimine (PEI), and used in the experiments 24 h after transfection.
HMESO cells stably expressing empty vector, BAP1, or BAP1(C91S) were generated through transient transfection of the respective plasmid DNA vectors using PEI. Cells were selected using 1.5 mg ml −1 G418 to obtain monoclonal populations. Colonies were then grown in 0.5 mg ml −1 G418 and tested for BAP1 overexpression via western blot. Western blot. Total cell (fibroblast cell cultures, human mesothelial cells, HEK293, PPM-Mill, Phi, HMESO, Rob, macrophages, as indicated in the figures) lysates were prepared in M-PER (Thermo Scientific, catalogue number 78501) reagent supplemented with proteases and phosphatases inhibitors (2 mM Na 3 VO 4 , 2 mM NaF, 50 nM okadaic acid, 1 mM PMSF and protease inhibitor cocktail) and 1 mM DTT.
Cleaved caspase-3 levels were analysed in fibroblasts treated with either vehicle or 100 μM H 2 O 2 , 10 μM C2-ceramide (C2-Cer), 10 μM menadione (Men), 10 μM 5-fluorouracil for 6 h in DMEM supplemented with 0.1% FBS. When indicated, fibroblasts were silenced for 24 h or transduced with adenoviruses for 36 h as described above. Human mesothelial cells were seeded in DMEM supplemented with 20% FBS, followed by transfection with HiPerfect for 24 h, and then treated with 200 μM H 2 O 2 for 6 h, or 5 μg cm −2 crocidolite for 24 h, in 0.1% FBS medium. THP-1 cells were treated with 20 μM TPA for 48 h to induce monocyte differentiation into macrophages; subsequently cells were transfected, in 1% FBS media, with control scrambled siRNA, siBAP1#1, and siBAP1#5 for 24 h, and then treated with 5 μg cm −2 crocidolite asbestos for an additional 24 h.
Protein extracts were quantified using the Bradford assay (Bio-Rad Laboratories); 7 μg of proteins were loaded and separated on NuPAGE Novex 4-12% Bis-Tris Gel (Life Technologies), and electron-transferred to PVDF (polyvinylidene difluoride) or nitrocellulose membrane according to standard procedures. Antibodies. Primary antibodies used were α-tubulin (4G1) (Santa Cruz Biotechnology, catalogue number sc-58666), BAP1 (C-4) (Santa Cruz Biotechnology, catalogue number sc-28383), BAP1 (D7W7O) (Cell Signaling, catalogue number 13271), BAP1 (H-300) (Santa Cruz Biotechnology, catalogue Letter reSeArCH number sc-28236), anti-human CD90 (BD Biosciences, catalogue number 561558), Caspase-3 (Cell Signaling, catalogue number 9662), Flag (Sigma-Aldrich, catalogue number F7425), Histone H2A.X (D17A3) (Cell Signaling, catalogue number 7631), anti-phospho-Histone H2A.X (Ser139) (EMD Millipore, catalogue number 05-636), H3 (Cell Signaling, catalogue number 4499), IP3R1 (Novus Biologicals, catalogue number NB120-5908), IP3R3 (BD Biosciences, catalogue number 610312), anti-Lamin B1 (abcam, catalogue number ab16048), c-myc (Bethyl Laboratories, catalogue number A190-105A), Myc-Tag (9B11) (Cell Signaling, catalogue number 2276), PDI (abcam, catalogue number ab31811) anti-VDAC1 (abcam, catalogue number ab15895). Secondary antibodies used were Goat anti-Mouse I gG (H+L) Secondary Antibody, HRP (Thermo Scientific, catalogue n umber 3 2 4 3 0 ), G o a t a n t i -R a bbit I g G ( H +L ) S e c on dary A n t ib ody, H R P ( T h er mo Scientific, catalogue number 32460), and Mouse TrueBlot ULTRA: Anti-Mouse Ig HRP (Rockland, catalogue number 18-8817-31). Quantitative PCR. Total RNA was extracted with TRIzol reagent (Invitrogen, catalogue number 15596-018), followed by phenol/chloroform extractions and ethanol precipitations. The RNA was treated with DNase (Promega) and its integrity and concentration assessed using an Agilent 2100 BioAnalyzer. Complementary DNA was synthesized using a High-Capacity cDNA Reverse Transcription Kit (Invitrogen, catalogue number 4368814) following the manufacturer's instructions. qPCR was performed in triplicate using TaqMan Universal Master Mix II (Invitrogen, catalogue number 4440040) and commercially available TaqMan Probes (Invitrogen) on a StepOnePlus system (Applied Biosystem). The mRNA levels were normalized using the geometric mean of three reference genes (B2M, 18S, and ACTB). Flow cytometry. For cell cycle analyses, fibroblast cell cultures were incubated with 10 μM bromodeoxyuridine (BrdU) for 3.5 h at 37 °C. Cells were collected by trypsinization, fixed, and permeabilized. Cell cycle positions were determined after staining BrdU with FITC (fluorescein isothiocyanate)-labelled anti-BrdU antibody and DNA with 7-ADD using the FITC BrdU Flow Kit (BD Biosciences, catalogue number 559619) according to the manufacturer's instructions. Cells not treated with BrdU, but incubated with FITC anti-BrdU antibody, were used to assess non-specific binding of the anti-BrdU antibody and to set the S-phase gate appropriately.
Cell death was measured in fibroblast cell cultures treated with vehicle or 100 μM H 2 O 2 for 6 h, in DMEM supplemented with 0.1% FBS media. Cells were collected and stained with FITC-labelled anti-annexin V and propidium iodide using an FITC Annexin V Apoptosis Detection Kit I (BD Biosciences, catalogue number 556547) according to the manufacturer's instructions. The percentage of late apoptotic cells was determined on the basis of the percentage of cells that were double-positive for both annexin V and propidium iodide (annexin V + /PI + ).
Primary human mesothelial cells treated with glass or crocidolite asbestos were collected and incubated (blocked) for 20 min with 1% BSA/PBS at 4 °C. Cells were stained with anti-human CD90 PE-Cy7 (BD Biosciences, catalogue number 561558) for 30 min at 4 °C. Cells were washed once with binding buffer and then stained with FITC annexin V and propidium iodide using an FITC Annexin V Apoptosis Detection Kit I (BD Biosciences, catalogue number 556547). After gating on CD90 + cells, the percentages of live cells (annexin V − /PI − ), early apoptotic cells (annexin V + /PI − ), and late apoptotic cells (annexin V + /PI + ) were determined.
For annexin V/propidium iodide experiments, compensation was performed using unstained and single-stained cells, and positivity gates were established using the fluorescence minus one technique.
For all flow cytometry experiments, fluorescence was detected using a BD LSRFortessa flow cytometer (BD Biosciences) and data were analysed using FACSDiva software version 6.2 (BD Biosciences). The investigator was blinded to the genotype and experimental conditions of the samples while conducting the experiments and assessing the outcome. Immunofluorescence. Cells (fibroblast cell cultures or human mesothelial cells, as indicated in the figures) grown on 24-mm glass coverslips were fixed in 4% paraformaldehyde in PBS for 10 min and washed three times with PBS. Then, cells were permeabilized for 10 min with 0.1% Triton X-100 in PBS and blocked in PBS containing 2% BSA and 0.05% Triton X-100 for 1 h. Cells were incubated overnight at 4 °C with the indicated antibodies: BAP1 (C-4) (1:50), BAP1 (D7W7O) (1:50), BAP1 (H-300) (1:50), PDI (1:50), IP3R3 (1:50), Myc-Tag (1:75), or H3 (1:75). The appropriate isotype-matched, Alexa Fluor-conjugated secondary antibodies (Life Technologies, A11008 (633 goat anti-rabbit, 1:1,000), A-11010 (546 goat anti-rabbit, 1:1,000), and A11001 (488 goat anti-mouse, 1:1,000)) were used. Where indicated, cells were also loaded with 300 nM DAPI (Life Technologies) for 10 min. The coverslips were mounted with ProLong Gold Antifade reagent (Life Technologies), and the analysis of immunofluorescence was performed with a Zeiss LSM 510 confocal laser scanner microscope (Carl Zeiss, Gottingen, Germany) equipped with a 63× oil objective (numerical aperture 1.4) and ZEN lite 2.0 software, or with a Nikon SweptField confocal equipped with a CFI Plan Apo VC60XH objective (numerical aperture 1.4) (Nikon Instruments, Melville, New York, USA) and an Andor DU885 EM-CCD (charge-coupled device) camera (Andor Technology, Belfast, Northern Ireland, UK), or with an Olympus xcellence multiple wavelength high-resolution fluorescence microscopy system equipped with a 60× UPLSAPO objective, numerical aperture 1.35 (Olympus). Subcellular fractionation. Cell fractionation was performed as previously described 38 . Briefly, 10 9 cells (fibroblast cell cultures, human mesothelial cells, PPM-Mill, HEK293, as indicated in the figure panels) were harvested in PBS and washed by centrifugation at 500g for 5 min with PBS. The cell pellet was suspended in homogenization buffer (225 mM mannitol, 75 mM sucrose, 30 mM Tris-HCl pH 7.4, 0.1 mM ethylene glycol-bis(β-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA), and PMSF (phenylmethylsulfonyl fluoride)) and gently disrupted by Dounce homogenization. The homogenate was centrifuged twice at 600g for 5 min to remove nuclei and unbroken cells, and the resultant supernatant was centrifuged at 10,300g for 10 min to pellet crude mitochondria. The supernatant was again centrifuged at 20,000g for 30 min. Further centrifugation of the supernatant at 100,000g for 90 min (70-Ti rotor; Beckman) resulted in the isolation of ER (pellet) and cytosolic fraction (supernatant).
To purify mitochondria, the crude mitochondrial fraction was suspended in isolation buffer (250 mM mannitol, 5 mM HEPES pH 7.4, and 0.5 mM EGTA) and subjected to Percoll gradient centrifugation (Percoll medium: 225 mM mannitol, 25 mM HEPES pH 7.4, 1 mM EGTA, and 30% v/v Percoll) in a 10 ml polycarbonate ultracentrifuge tube, at 95,000g for 30 min (SW40 rotor; Beckman). Purified mitochondria were then washed by centrifugation at 6,300g for 10 min to remove the Percoll and finally suspended in isolation medium. All centrifugation steps were performed at 4 °C.
To isolate nuclei, cells were collected by centrifugation at 200g for 5 min, washed once with ice-cold PBS, suspended in hypotonic buffer (10 mM HEPES pH 7.4, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 0.5 mM PMSF), and incubated 15 min on ice. NP40 (Fluka) was added to a final concentration of 0.5% and the mixture was homogenized with a pestle grinder using 30 strokes. The efficiency of shearing the cytoplasm from the nuclei was monitored under a light microscope by staining with Trypan blue. Homogenates were centrifuged at 14,000g for 30 s to sediment the nuclei. Nuclei were washed once in PBS and further centrifuged at 14,000g for 1 min. Nuclei were finally suspended in hypotonic buffer (20 mM HEPES pH 7.4, 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF), incubated on ice for 30 min, vortexed every 5 min, and centrifuged at 16,000g for 10 min; the supernatant was collected as nuclear homogenate. Immunoelectron microscopy. Fibroblast cell cultures were fixed with 2% paraformaldehyde, 0.2% glutaraldehyde in 0.1 M phosphate buffer pH 7.4 for 1 h at room temperature. Samples were washed in PBS, embedded in 12% gelatin, infiltrated in 2.3 M sucrose, and frozen in liquid nitrogen. Ultrathin cryo-sections were obtained using a Leica EM FC7 cryo-ultramicrotome and collected on copper-formvar-carbon-coated grids. BAP1 localization was revealed using BAP1 (D7W7O) rabbit monoclonal anti-BAP1 antibody (Cell Signaling, catalogue number 13271) and conjugated 10 nm protein A-gold according to published protocols 39 . Sections were imaged with a Zeiss LEO 512 electron microscope and images were acquired by a 2k × 2k bottom-mounted slow-scan Proscan camera controlled by the EsivisionPro 3.2 software. Intracellular Ca 2+ concentration measurements. Cytosolic and mitochondrial Ca 2+ concentration measurements with aequorins. Cells (fibroblast cell cultures, human mesothelial cells, MAF, Phi, HMESO, macrophages, as indicated in the figures) grown on 13-mm round glass coverslips were transduced (or co-transduced in BAP1 gene expression experiments) with aequorin encoded by an adenoviral construct (cytosolic aequorin, cytAEQ; mitochondria-targeted aequorin, mtAEQ; or the low-affinity mitochondrial aequorin, mtAEQmut). The coverslip with the cells was incubated with 5 μM coelenterazine for 2-3 h in 0.1% FBS medium, and then transferred to the perfusion chamber. All aequorin measurements were performed in Krebs-Ringer buffer (135 mM NaCl, 5 mM KCl, 1 mM MgSO 4 , 0.4 mM KH 2 PO 4 , 5.5 mM glucose, 20 mM HEPES, pH 7.4) supplemented with 1 mM CaCl 2 . Agonists and other drugs were added to the same medium, as specified in the text. The experiments were terminated by lysing the cells with 100 μM digitonin in a hypotonic Ca 2+ -rich solution (10 mM CaCl 2 in H 2 O), thus discharging the remaining aequorin pool. The light signal was collected and calibrated into [Ca 2+ ] values by an algorithm based on the Ca 2+ response curve of aequorin at physiological conditions of pH, [Mg 2+ ], and ionic strength, as previously described 36 . Ca 2+ measurements were conducted using a luminometer in cells transduced with aequorin, which is a bio-luminescent Ca 2+ probe. Note that [Ca 2+ ] was measured only in cells containing aequorin, specifically providing the results only of the transduced cells, and therefore were not influenced by the background not-transduced cells. To ensure that cells transduced with aequorin Letter reSeArCH also contained BAP1, BAP1(C91S), or BAP1-targeted chimaeras, we used a transduction ratio of 1 (aequorin) to 3 (BAP1).
ER Ca 2+ concentration measurements with D1ER. Luminal Ca 2+ dynamics were measured using single-cell Ca 2+ imaging and the Ca 2+ -sensitive fluorescence resonance energy transfer (FRET)-based cameleon protein D1ER 23, 37 . Fibroblasts were cultured on 24-mm coverslips. When the cells reached 60% confluence, they were transfected with D1ER. After 36 h, cells were imaged on a Zeiss Axiovert 200M microscope with a cooled CCD camera (Photometrics), equipped with a C-apochromat 40× oil objective (numerical aperture 1.2) and controlled by MetaFluor 7.0 software (Universal Imaging). Emission ratio imaging of the cameleon was accomplished by using a 436DF20 excitation filter, a 450 nm dichroic mirror, and two emission filters (475/40 for enhanced cyan fluorescent protein (ECFP) and 535/25 for citrine) controlled by a Lambda 10-2 filter changer (Sutter Instruments). Fluorescence images were background corrected. Exposure times were typically 100-200 ms, and images were collected every 5-15 s. The FRET signal (yellow fluorescent protein (YFP)/CFP) was normalized to the CFP emission intensity, and changes in ER Ca 2+ were expressed as the ratio of the emissions at 535 and 470 nm. Cells were treated with 1 μM bradykinin or 500 μM H 2 O 2 as indicated in the figures, where representative changes in ER [Ca 2+ ] in BAP1 WT and BAP1 +/− fibroblasts are expressed as D1ER ratios (YFP/CFP) normalized to initial values.
Cytosolic Ca 2+ concentration measurements with Fura-2/AM. Dynamic measurements of cytosolic Ca 2+ response were performed using the fluorescent Ca 2+ indicator Fura-2/AM (Life Technologies). Fibroblasts were grown on 24-mm coverslips and incubated at 37 °C for 30 min in 1 mM Ca 2+ /Krebs-Ringer buffer supplemented with 2.5 mM Fura-2/AM, 0.02% Pluronic F-68 (Sigma), 0.1 mM sulfinpyrazone (Sigma). Cells were then washed and supplied with 1 mM Ca 2+ / Krebs-Ringer buffer. To determine cytosolic Ca 2+ response, the cells were placed in an open Leyden chamber on a 37 °C thermostated stage and exposed to 340/380 nm wavelength light using the Olympus xcellence multiple wavelength high-resolution fluorescence microscopy system. H 2 O 2 was added to the 1 mM Ca 2+ /Krebs-Ringer buffer, and crocidolite asbestos or glass added at concentrations of 5 μg cm −2 . Ca 2+ release was recorded upon stimulation as indicated in the figures. To determine whether the Ca 2+ release occurred via the ER or whether it was secondary to the plasma membrane influx, fibroblasts were loaded with fluorescent Ca 2+ indicator Fura-2/AM for 30 min in Ca 2+ -free Krebs-Ringer buffer supplemented with 0.1 mM EGTA. Cells were placed in an open Leyden chamber on a 37 °C thermostated stage and exposed to 340/380 wavelength light, as described above. Bradykinin was added to the Krebs-Ringer buffer, and Ca 2+ release was recorded upon stimulation as indicated in the figures. The fluorescence data collected were expressed as emission ratios at 340/380 nm. In the figures, the kinetic of the cytosolic Ca 2+ responses after H 2 O 2 or bradykinin stimulation is presented as the ratio of fluorescence at 340/380 nm in cells loaded with Fura-2/AM. Dynamic measurements of cytosolic Ca 2+ response after irradiation with UVA (irradiated for 5 min with the Olympus xcellence Hg lamp, model MT-ARC-Hg, 150 W, light was filtered with a 340 filter) or UVB (irradiated at 312 nm for 20 min, at a 2 cm fixed distance, with a Spectroline model ENB-280C/F, 220 V, 50 Hz, 0.17 A) were performed using the fluorescent Ca 2+ indicator Fura-RED (Life Technologies). Fibroblasts grown on 24-mm coverslips were incubated at 37 °C for 60 min in 1 mM Ca 2+ /Krebs-Ringer buffer supplemented with 2.5 mM Fura-RED, 0.02% Pluronic F-68 (Sigma), 0.1 mM Sulfinpyrazone (Sigma). Cells were then washed and supplied with 1 mM Ca 2+ /Krebs-Ringer buffer. To determine the cytosolic Ca 2+ response, the cells were placed in an open Leyden chamber on a 37 °C thermostated stage and exposed to 406/494 nm wavelength light using the Olympus xcellence multiple wavelength high-resolution fluorescence microscopy system. The fluorescence data collected were expressed as emission ratios at 406/494 nm. In the figures, the kinetics of the cytosolic Ca 2+ responses after ultraviolet irradiation are presented as the ratio of fluorescence at 406/494 nm in cells loaded with Fura-RED. Statistical analyses refer to normalized FRET fluorescence ratio over time after irradiation (Σ(F 406 nm /F 494 nm )).
Single-cell mitochondria Ca 2+ measurements with 4mtD3cpv. BAP1 WT and BAP1 +/− fibroblasts were transfected with the 4mtD3cpv 23,37 plasmid, as described above. When indicated, co-transfection or silencing were also performed, as described above. After 24 h, cells were imaged on a Zeiss Axiovert 100TV microscope with a cooled CCD camera R3 Retiga (Q-Imaging), equipped with a Fluar 40×/1.3 oil objective and controlled by MetaFluor 7.7.2.0 software (Molecular Devices). Emission ratio imaging of the cameleon was accomplished with a 436DF20 excitation filter, a 450 nm dichroic mirror, and two emission filters (475/40 for ECFP and 535/25 for citrine), controlled by a Lambda 10-2 filter changer (Sutter Instruments). Fluorescence images were background corrected. Exposure times were typically 50-100 ms, and images were collected every 1-2 s. Mitochondrial Ca 2+ uptake was followed over time after stimulation with 1 μM bradykinin or 100 μM H 2 O 2 , as indicated in the figures. In the figures, representative traces from single experiments are presented as normalized FRET fluorescence ratio intensity. Statistical analyses refer to normalized FRET fluorescence ratio peak intensity after bradykinin stimulation, or Σ(FRET fluorescence ratio) over time after H 2 O 2 stimulation. Co-immunoprecipitation. Cells (fibroblast cell cultures or HEK293, as indicated in the figures) were collected and lysed in buffer containing 30 mM Tris-HCl, at pH 7.5, 50 mM NaCl, 1% NP-40. To map the BAP1 and IP3R3 binding region, HEK293 cells were transiently transfected using polyethylenimine, collected 24 h later, and lysed in 50 mM Tris, at pH 7.5, 150 mM NaCl, glycerol 10%, 1 mM EDTA, 50 mM NaF, and NP-40 0.1%. All the buffers were supplemented with proteases and phosphatase inhibitors. Extracted proteins were pre-cleared by incubating lysates with G-coated Sepharose beads (GE Healthcare) for 1 h at 4 °C, then the supernatant (700 μg, referred to as 'Input') was incubated overnight with IP3R3 antibody at 4 °C; precipitation of the immune complexes was performed with G-coated Sepharose beads for 4 h at 4 °C, according to the manufacturer's instructions. Alternatively, the supernatant was incubated for 3 h at 4 °C with Flag M2 resin (Sigma, catalogue number A2220) or HA resin (Roche, catalogue number 11815016001). After immunoprecipitation, the beads were washed three times with lysis buffer, at 4 °C, and suspended in 40 μl of 2× Laemmli buffer. Ten to twenty microlitres (depending on experiment) were loaded on the gel and the samples were processed by SDSpolyacrylamide gel electrophoresis (SDS-PAGE) and analysed by western blot. Duolink proximity ligation in situ assay. BAP1 WT and BAP1 +/− fibroblasts were fixed in 4% paraformaldehyde for 10 min at 37 °C, and then washed in PBS. Cells were permeabilized with 0.05% Triton X-100 (v/v in PBS) for 10 min at 37 °C. Unspecific binding sites were blocked by incubating cells in 2% BSA (w/v in PBS/0.05% Triton) for 1 h at 37 °C. Cells were then incubated overnight at 4 °C with proximity ligation assay oligonucleotide probes conjugated to primary antibodies specific for IP3R3 (BD Biosciences, catalogue number 610312) and BAP1 (Santa Cruz Biotechnology, catalogue number sc-28236), in diluent buffer according to the Duolink In Situ -Probes Maker protocol (Sigma-Aldrich, catalogue number DUO92101). Detection was performed according to the manufacturer's protocol. Briefly, a ligation-ligase solution was added to each sample for 30 min at 37 °C, and then washed twice for 2 min with 1× Duolink In Situ Wash Buffer A. An amplification-polymerase solution was added for 100 min at 37 °C, and then washed twice for 10 min with 1× Duolink In Situ Wash Buffer B. The slides were mounted using Duolink In Situ Mounting Medium with DAPI. Protein-protein interactions appeared as red dots. Images were processed and red dots counted using the Analyze Particles ImageJ software plugin. In vitro ubiquitylation and deubiquitylation assays. In vitro ubiquitylation assays were performed as previously described 40 . Briefly, Flag-tagged IP3R3(NT) was co-transfected with either empty vector, Myc-tagged BAP1, or the catalytic dead mutant BAP1(C91S) into HEK293 cells. Twenty-four hours after transfection, Flag-IP3R3(NT) was immunoprecipitated with anti-Flag M2 agarose beads. The beads were washed three times in lysis buffer and once in PBS. In vitro ubiquitylation assays were performed on immunoprecipitated beads in a volume of 50 μl, containing 50 mM Tris-HCl, at pH 7.5, 5 mM MgCl 2 , 1 μM okadaic acid, 2 mM ATP, and 0.5 mM DTT, 0.1 μM E1 (Boston Biochem), 0.25 μM Ubch3 (Boston Biochem), 0.25 μM Ubch5c (Boston Biochem), and 2.5 μg μl −1 human ubiquitin (Boston Biochem). Samples were incubated for 1 h at 33 °C, washed twice with PBS at 4 °C, suspended in 2× Laemmli buffer, and analysed by SDS-PAGE and western blot.
For in vitro deubiquitylation assays, HEK293 cells were transfected with Flag-IP3R3(NT), Myc-BAP1, or Myc-BAP1(C91S). Flag-IP3R3(NT) was immunopurified and in vitro ubiquitylation was performed. Then, beads were washed twice with PBS at 4 °C, and suspended in deubiquitylation reaction buffer containing 50 mM Tris-HCl, at pH 7.5, 5 mM MgCl 2 , 1 μM okadaic acid, 2 mM ATP, and 0.5 mM DTT. Myc-BAP1 and Myc-BAP1(C91S) were purified with a c-Myctagged Protein Mild Purification Kit version 2 (MBL International, catalogue number 3305), eluted with c-Myc-tag peptide accordingly to the manufacturer's instructions, and added to the deubiquitylation reaction buffer. Samples were incubated at 33 °C for the indicated times, then beads were washed twice with PBS at 4 °C, and suspended in 2× Laemmli buffer. Samples were processed by SDS-PAGE and analysed by western blot. Neutral comet assay. BAP1 WT and BAP1 +/− fibroblasts were plated at 8 × 10 5 cells per T25 flask and incubated overnight, then the medium was replaced with cold PBS, and cells were irradiated, on ice, with 6 Gy ionizing radiation dose using a cabinet X-ray system (Faxitron). After ionizing radiation, cells were collected immediately (detached using trypsin, harvested, and frozen in 90% FBS/10% DMSO) or incubated in complete growth medium for the indicated time before being collected. Neutral comet assay and data analysis were performed by Trevigen (https://www.trevigen.co). Samples were tested using Trevigen's Comet
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Assay Electrophoresis System. Images were captured and analysed using a Loats Associates Comet Analysis System. At least 200 cells were scored per sample. Trevigen Neutral Control Cells were used as electrophoresis controls. Data from triplicate wells for each sample were pooled to calculate the median and mean, and expressed as tail moment. Experiments were conducted and analysed by investigators blinded to the genotype and experimental conditions of the samples. Kinetics of H2A.X phosphorylation. BAP1 WT and BAP1 +/− fibroblasts were plated and treated with 6 Gy ionizing radiation, as described for neutral comet assay. In ultraviolet radiation experiments, fibroblasts were plated at 3.5 × 10 5 cells per 60 mm dish and incubated overnight, then the medium was replaced with PBS and cells were irradiated with 50 mJ cm −2 of either UVA (340 nm, using a UVA-340 sunlamp, Atlas Material Testing Technology) or UVB (290-315 nm, using a Philips UVB Broadband TL 40 W/12 RS SLV/25). For UVA and UVB, spectral output was quantified with a General UV-513/AB Digital UV AB Light Meter.
After radiation, cells were collected immediately or incubated in complete growth medium for the indicated time before being collected. Dry cell pellets were immediately store at −80 °C. Samples were boiled at 95 °C for 10 min. Total cell lysates were immediately prepared by sonication in 200 μl of buffer containing 25 mM Tris-HCl pH 7.5 and 1% SDS. After centrifugation, the supernatant was collected and the protein concentration determined using a Pierce BCA Protein Assay Kit (Life Technologies, catalogue number 23225). SDS-PAGE and western blot were conducted according to standard procedure (see above). Clonogenic survival assay after exposure to ionizing or ultraviolet radiation. In ionizing radiation experiments, BAP1 WT and BAP1 +/− fibroblasts were plated and treated with the indicated ionizing radiation, as described for the neutral comet assay. In ultraviolet radiation experiments, fibroblasts were plated at 3.5 × 10 5 cells per 60 mm dish and incubated overnight, then the medium was replaced with PBS and the cells were irradiated with 25 mJ cm −2 as described above in the section Kinetics of H2A.X phosphorylation.
After irradiation, fibroblasts were trypsinized, harvested, counted, and plated on six-well plates. Cells were incubated at 37 °C for 14 days (the tissue culture medium was changed twice a week) to allow colony formation. The surviving colonies were washed with PBS and fixed and stained with 0.5% crystal violet in 50/50 methanol/ water for 10 min, followed by three washes with PBS. Colonies were counted and the plating efficiencies were calculated for untreated cells as the ratio of the number of colonies to the number of cells seeded. The surviving fractions, expressed in terms of plating efficiency, were calculated as the ratio between the number of colonies arising after treatment and the number of cells seeded × plating efficiency. In vitro cell transformation assay. The human mesothelial cell transformation assay was done according to an established protocol 28, 41 . Human mesothelial cells were cultured and seeded in six-well plates at a density of 3 × 10 5 cells per well in 20% FBS growth medium. After 24 h, the medium was switched to 0.1% FBS, and transfection performed with HiPerfect as described above. When indicated, transduction of cells was performed 6 h after HiPerfect transfection. Twenty-four hours later, human mesothelial cells were pre-treated with 10 ng ml −1 recombinant human TNFα (PromoKine, catalogue number C-63720) or 0.1% BSA (vehicle), and incubated for an additional 24 h. At this time point, human mesothelial cells were exposed to 5 μg cm −2 crocidolite asbestos fibres or PBS (control) for 48 h. Human mesothelial cells were then maintained in 10% FBS supplemented with 10 ng ml −1 TNFα. Transfection transduction was repeated every 96 h in fresh 10% FBS supplemented with 10 ng ml −1 TNFα. Media were completely replaced 24 h after transfection transduction, then cells were incubated at 37 °C for the remaining 72 h. After 2-3 weeks, three-dimensional foci were identified and counted under a light microscope. Experiments were performed three times. Statistics and reproducibility. Statistical analyses were performed using Student's two-tailed unpaired t-tests, unless otherwise specified. P values <0.05 were considered statistically significant and marked with asterisks (*P < 0.05; **P < 0.01; ***P < 0.001), as indicated in the figure legends. All data collected met the normal distributions assumption of the test. Data are represented as mean ± s.e.m., unless otherwise specified. The exact sample size (n) for experimental groups/conditions, and whether samples represent technical or cell culture replicates, are indicated in the figure legends and Supplementary Tables. The exact sample sizes of Ca 2+ experiments are reported in Supplementary Tables  1 and 2 . For all other experiments, unless otherwise specified, the results shown are representative of experiments independently conducted three times that produced similar results. Data availability. The authors declare that the data supporting the findings of this study are either available within the paper (and its Supplementary Information files) or are available from the corresponding authors upon reasonable request.
Extended Data Figure 5 | BAP1 stabilizes IP3R3 . a, Defining the linear dynamic range of BAP1 and IP3R3 detection by western blot. The top panel shows a representative western blot performed on a twofold dilution series (from 60 to 0.9375 μg) of total cell homogenates from BAP1 +/− and matched control BAP1 WT fibroblasts. Protein levels were determined using the following primary antibodies: BAP1 (C-4), Santa Cruz Biotechnology, catalogue number sc-28383, 1:300; IP3R3, BD Biosciences, catalogue number 610312, 1:500; α-tubulin (4G1), Santa Cruz Biotechnology, catalogue number sc-58666, 1:15,000. A horseradish peroxidase-conjugated secondary antibody (Stabilized Peroxidase Conjugated Goat Anti-Mouse, Thermo Scientific, catalogue number 32430; 1:1,000 for BAP1 and IP3R3, 1:5,000 for α-tubulin) was used to generate the chemiluminescent signal captured on autoradiography film. Digital images were acquired, then densitometric analysis of the intensity of the bands was performed using ImageJ, and expressed as arbitrary optical densitometry units (AU). The lower three panels show the arbitrary optical densitometry units for IP3R3, BAP1, and α-tubulin, plotted against the protein load. The dotted lines define the linear dynamic range of protein load for BAP1, IP3R3, and α-tubulin detection. b, c, Densitometric analysis of IP3R3 protein levels normalized to α-tubulin in fibroblasts from W (b) and L (c) family members, related to Fig. 2A, B . Densitometry of bands in BAP1 +/− fibroblasts is expressed relative to BAP1 WT fibroblasts (100%), matched by gender and age as indicated in Supplementary  Fig. 1a, b ; data shown as mean ± s.e.m. of n = 4 (b) and n = 3 (c) biological replicates per condition, representative of three independent experiments; *P < 0.05 calculated using two-tailed paired Student's t-tests. d, Malignant mesothelioma cell lines with mutated BAP1 contained reduced amounts of IP3R3: PPM-Mill (wild-type BAP1), Phi (mutated BAP1 with shorter splicing isoform), HMESO (mutated BAP1 alternative splicing, shorter protein), and Rob (BAP1 null). e, Quantitative PCR analysis of ITPR3, the gene that codes for IP3R3. mRNA expression levels were normalized using the geometrical mean of B2M, 18S, and ACTB reference genes in BAP1 WT and BAP1 +/− fibroblasts. mRNA expression levels in BAP1 +/− fibroblasts are expressed relative to BAP1 WT . Data shown as mean ± s.e.m. of n = 6 technical replicates, representative of three independent experiments in biological replicates. For western blot source images, see Supplementary  Fig. 2. 
